Catonsville, MD, United States of America

Lucy M Anderson

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2015.


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Cancer Treatment by Lucy M Anderson

Introduction

Lucy M Anderson is a prominent inventor based in Catonsville, MD (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of pharmaceutical compositions. Her work focuses on utilizing diazeniumdiolated compounds to enhance the effectiveness of cancer therapies.

Latest Patents

Lucy M Anderson holds a patent for her invention titled "Diazeniumdiolated compounds, pharmaceutical compositions, and method of treating cancer." This patent discloses a method of treating cancer in patients by administering an effective amount of a diazeniumdiolated compound or a pharmaceutically acceptable salt thereof. The method targets cancer cells that exhibit elevated levels of reactive oxygen species (ROS) and decreased levels of specific proteins compared to normal cells. The patent also includes details on enhancing chemotherapeutic treatments and the use of high-energy radiation.

Career Highlights

Lucy M Anderson is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her role at this esteemed institution allows her to contribute to groundbreaking research in the medical field.

Collaborations

Some of her notable coworkers include Anna E Maciag and Larry K Keefer, who collaborate with her on various research projects aimed at improving cancer treatment methodologies.

Conclusion

Lucy M Anderson's innovative work in developing diazeniumdiolated compounds represents a significant advancement in cancer treatment. Her contributions continue to pave the way for new therapeutic strategies that could improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…